MedVital, a medtech startup engaged on pores and skin restore and regeneration applied sciences, has raised Rs 18 crore in a development funding led by Alkemi Progress Capital, with participation from Dr. Sanjay Arora, Shubhan Ventures, and present buyers.

The startup had beforehand raised a spherical led by 4point0 Well being Ventures and entrepreneur buyers.

The recent capital can be used to broaden operations, speed up product improvement, and construct capabilities throughout units, biomaterials, and biologics, whereas additionally bettering provide chain effectivity.

Based in 2024, MedVital operates on the intersection of superior wound care, regenerative aesthetics, and continual pores and skin circumstances. The startup’s premise is that pores and skin and hair circumstances, whether or not associated to wounds, ageing, or continual dermatological points, are basically linked to gaps within the physique’s restore and regeneration processes.

MedVital is creating evidence-based applied sciences to handle these gaps and make them accessible throughout particular scientific use instances.

“Pores and skin, the physique’s largest organ, is more and more impacted by ageing, diabetes and a rising burden of continual dermatological circumstances, but entry to revolutionary, evidence-based applied sciences stay restricted. We’re constructing scientific pushed applied sciences spanning biomaterials, gadget primarily based methods, biologics throughout wound care, aesthetics, and continual dermatology,” mentioned Dr. Varun Gupta, Co-Founding father of MedVital.

MedVital at the moment operates by way of two distinct product portfolios. The primary is NoWound, its superior wound care vary, which incorporates Detrimental Strain Wound Remedy and a chitosan-based liquid bandage developed for hospital settings.

Superior wound care adoption in India continues to be at a comparatively early stage regardless of the dimensions of scientific want, and MedVital sees this as a major development alternative. The startup claims to have established scientific traction with adoption throughout greater than 200 company and public healthcare establishments.

The second portfolio is Elyara, which the startup has launched within the regenerative medical aesthetics house. Elyara focuses on non-invasive pores and skin and hair restoration, drawing on peptide-led signalling and regenerative pathways.

Alka Goel, Founder and Managing Accomplice at Alkemi Progress Capital, mentioned, “MedVital is addressing a big and rising scientific want with a platform-led method. The workforce has demonstrated early hospital adoption, robust product depth, and disciplined execution, positioning the corporate to construct a globally related regenerative care enterprise from India.”

Dr. Sanjay Arora, Founding Accomplice at Shubhan Ventures, mentioned, “The corporate’s emphasis on product high quality, regulatory readiness, and long-term functionality constructing stands out. These are crucial foundations for sustainable scale in healthcare.”